Amanote Research
Register
Sign In
Mycophenolate Mofetil Prevents a Clinical Relapse in Patients With Systemic Lupus Erythematosus at Risk
Annals of the Rheumatic Diseases
- United Kingdom
doi 10.1136/ard.62.6.534
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Date
June 1, 2003
Authors
M Bijl
Publisher
BMJ
Related search
Mycophenolate Mofetil Reduces STAT3 Phosphorylation in Systemic Lupus Erythematosus Patients
JCI insight
Medicine
Correction: Steady-State Mycophenolate Mofetil Pharmacokinetic Parameters Enable Prediction of Systemic Lupus Erythematosus Clinical Flares: An Observational Cohort Study
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Mycophenolate Mofetil in Patients With Refractory Systemic Autoimmune Myopathies: Case Series
Advances in Rheumatology
Rheumatology
Herpes Zoster in Patients With Systemic Lupus Erythematosus: Clinical Features, Complications and Risk Factors
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Tuberculosis in Patients With Systemic Lupus Erythematosus.
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
15. Clinical Manifestations and Treatment in Patients With Systemic Lupus Erythematosus
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
Increased Risk of Depression in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus: A Danish Nationwide Cohort Study
British Journal of Dermatology
Dermatology
Medicine
Risk Factors for Infectious Complication in Patients With Systemic Lupus Erythematosus
Internal Medicine
Internal Medicine
Medicine
The Effect of Mycophenolate Mofetil on Disease Development in the gld.apoE−/− Mouse Model of Accelerated Atherosclerosis and Systemic Lupus Erythematosus
PLoS ONE
Multidisciplinary
